Frontal fibrosing alopecia:a descriptive cross-sectional study of 711 cases in female patients from the UK
- McSweeney, S. M.
- Christou, E. A. A.
- Dand, N.
- Boalch, A.
- Holmes, S.
- Harries, M.
- Palamaras, I.
- Cunningham, F.
- Parkins, G.
- Kaur, M.
- Farrant, P.
- McDonagh, A.
- Messenger, A.
- Jones, J.
- Jolliffe, V.
- Ali, I.
- Ardern-Jones, M.
- Mitchell, C.
- Burrows, N.
- Atkar, R.
- Banfield, C.
- Alexandroff, A.
- Champagne, C.
- Cooper, H. L.
- Patel, G. K.
- Macbeth, A.
- Page, M.
- Bryden, A.
- Mowbray, M.
- Wahie, S.
- Armstrong, K.
- Cooke, N.
- Goodfield, M.
- Man, I.
- de Berker, D.
- Dunnil, G.
- Takwale, A.
- Rao, A.
- Siah, T.-W.
- Sinclair, R.
- Wade, M. S.
- Bhargava, K.
- Fenton, D. A.
- McGrath, J. A.
- Tziotzios, C.
Publication date
December 2020
DOIAbstract
Frontal fibrosing alopecia (FFA) is an inflammatory primary scarring alopecia of uncertain aetiology that represents a variant of lichen planopilaris.1 It predominantly, although not exclusively, affects post-menopausal women.2 Its pathogenesis is characterised by immune-mediated follicular destruction at the level of the hair bulge, which leads to a clinical phenotype of progressive fronto-temporal hair and eyebrow loss that is often preceded by widespread body hair loss.</p
Add to ORKG